# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CLSA initiates coverage on NuScale Power (NYSE:SMR) with a Outperform rating and announces Price Target of $11.
Decommissioned Michigan nuclear plant revived by Holtec after shut down by Entergy in 2022 due to high costs. Growing AI and da...
- Prepared Remarks
NuScale Power (NYSE:SMR) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.13) ...
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...
Hunterbrook is a known short-seller that has a vested interest in sensationalizing information to manipulate the stock market. ...